Mass Physician. on the effectiveness of the COVID-19 vaccine against variants

Mass Physician. on the effectiveness of the COVID-19 vaccine against variants



WE, DOCTOR. BEN: THAT’S PROMISING. THIS INFORMATION COMES FROM A PRESS RELEASE. I KNOW YOU’RE STILL WAITING TO REVIEW THE REAL DATA, BUT WHAT DOES THIS TELL YOU SO FAR ABOUT SAFETY AND EFFECTIVENESS? AC >> I WILL BE CAREFULLY OPTIMISTIC. YOU LOOK AT THE RESTUL THEY HAVE REPORTED. THEY SHOWED WHAT IN PARTICULAR WHAT CALDLE A BIVALIANT VACCINE THAT HASHES THE ORIGINAL AND A VARIANT OF OMICRON LEADS TO MUCH HIGHER ANTIBODY PROTECTION. SINCE THANKSGIVING, THE MTOS OF OUR INFECTIONS ARE OMICRON. IT’S TIME TO MEAK THE SWITCH. ERIKA: MODERNA CEO SAYS, THIS NEW PICTURE IS THE COMPANY’S FIRST CANDIDATE FOR A MORE BOOERST DOSE THIS FALL, BUT AS YOU KNOW THIS VIRUS MUTESAT VERY QUICKLY. COULD THIS PHOTO BECOME OBSOLETE BEFORE IT IS DISTRIBUTED? >> I LEARNED NOT TO MAKE TOO MUCH 100% CONFIDENCE PREDICTIONS. I SAY THIS, IT IS VERY KELILY THAT OMICRON IN SOME FORM OR ANOTHER WILL BE CIRCULATING WHEN IT COMES IN THE FALL. AS WE KNOW, CASES OF COVID-19 ARE ALWAYS RISING, ESPECIALLY HERE IN THE NORTHERN PART OF THE COUNTRY, IN AUTUMN AND WINTER. I would say for people who haven’t had the fourth booster, especially if they’ve already had COVID, if they’ve had their three shots in addition to COVID, it’s reasonable for them to defer vaccination with the fourth shot until the TSHI is available. Ben: THANK YOU. I ALSO WANT TO ASK YOU ABOUT THE MONKEYPOX OUTBREAK. AS YOU KNOW, THE CDC HAS RAISED ITS ALERT TO LEVEL 2, WHICH ENCOURAGES PEOPLE TO PRACTICE ENHANCED PRECAUTIONS. WHAT DOES THAT MEAN? >> IF WE LOOK SO FAR AT THE CASES THAT HAVE REPORTED BNEE WORLDWIDE OUTSIDE OF AFRICA, MOST OF THEM HAVE OCCURRED IN SEX WITH MEN WHERE THEY HAVE INVESTIGATED THE VIRUS SEXUALLY. OUR TESTS ARE NOT YET SUFFICIENTLY ACCELERATED TO ALLOW US TO DIAGNOSE ALL CASES. BUT, I TNKHI IT IS REASONABLE TO BE CAREFUL WHEN WE HAVE NO FALSE KNOW HOW WIDESPRDEA THE EPIDEMIC

Mass Physician. on the effectiveness of the COVID-19 vaccine against variants

Dr. Paul Sax is Clinical Director of Infectious Diseases at Brigham and Women’s Hospital.

Dr. Paul Sax is Clinical Director of Infectious Diseases at Brigham and Women’s Hospital.

Comments are closed.